ROBITUSSIN COUGH CONTROL 100 MG / 5 ML — DIN 01931024
GUAIFENESIN : 100 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML · HALEON CANADA ULC · SYRUP · wholesale supply in Canada
Health Canada status: MARKETED
What is ROBITUSSIN COUGH CONTROL?
ROBITUSSIN COUGH CONTROL 100 MG / 5 ML contains GUAIFENESIN : 100 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 01931024, held by HALEON CANADA ULC, supplied as SYRUP for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Jun-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Opium Derivatives And Expectorants cost around the world?
Opium Derivatives And Expectorants is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Iceland publishes a max wholesale; Romania publishes a max producer price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Romania | max producer price | 1 | 4 | RON███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
5 pack listings across 2 brand entries and 2 price bases, refreshed 03 Sep 2026. Ranges span every Opium Derivatives And Expectorants pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Opium Derivatives And Expectorants in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
51 holders have a Canadian DIN containing Opium Derivatives And Expectorants, across 156 DINs, of which 25 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 15 | 6 | BENYLIN 2 COLD AND FLU WITH CODEINE, BENYLIN COUGH & CONGESTION EXTRA STRENGTH, BENYLIN COUGH AND COLD, BENYLIN COUGH AND CONGESTION, BENYLIN COUGH PLUS COLD RELIEF, +10 more | Sourceable in Canada |
| TEVA CANADA LIMITED | 12 | 5 | BALMINIL DM + DECONGESTANT + EXPECTORANT, BALMINIL DM + DECONGESTANT + EXPECTORANT EXTRA STRENGTH, BALMINIL DM + EXPECTORANT, BALMINIL DM + EXPECTORANT EXTRA STRENGTH, CALMYLIN, +7 more | Sourceable in Canada |
| HALEON CANADA ULC | 7 | 5 | JACK & JILL HONEY COUGH & COLD, ROBITUSSIN COUGH CONTROL, ROBITUSSIN DRY COUGH + MUCUS RELIEF, ROBITUSSIN EXTRA STRENGTH COUGH & COLD, ROBITUSSIN EXTRA STRENGTH COUGH CONTROL, +2 more | Sourceable in Canada |
| CRLS | 3 | 2 | COUGH & COLD RELIEF EXTRA STRENGTH, COUGH & COLD RELIEF REGULAR STRENGTH, MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH | Sourceable in Canada |
| JUNO OTC INC | 2 | 2 | COUGH & CHEST CONGESTION, COUGH & CONGESTION | Sourceable in Canada |
| RB HEALTH (CANADA) INC. | 2 | 2 | MUCINEX MULTI-ACTION CONGESTION, STUFFY NOSE & COUGH LIQUID, MUCINEX MULTI-ACTION WET & DRY COUGH LIQUID | Sourceable in Canada |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 5 | 1 | CONTAC COUGH & COLD SYRUP, ROBITUSSIN AC, ROBITUSSIN COUGH AND COLD, ROBITUSSIN HONEY CHILDREN'S COUGH & CONGESTION, ROBITUSSIN SUGAR FREE COUGH CONTROL | Sourceable in Canada |
| PROCTER & GAMBLE INC | 5 | 1 | DAYQUIL COUGH + CONGESTION, DAYQUIL COUGH DM + CONGESTION, VICKS CUSTOM CARE CHEST CONGESTION/COUGH, VICKS DAYQUIL COUGH COUGH & CONGESTION, VICKS PEDIATRIC FORMULA 44E LIQ | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 3 | 1 | COUGH AND ALLERGY SYRUP WITH CODEINE, DAMYLIN WITH CODEINE SYRUP, PULMORPHAN | Sourceable in Canada |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 9 | 0 | COUGH SYR W CODEINE DIPHENHYD HCL & AMMON CL, COUGH SYR W.COD. PSEUDOEPHED.HCL GUAIFENESIN, COUGH SYRUP DM DECONGESTANT EXPECTORANT, COUGH SYRUP DM DECONGESTANT FOR CHILDREN, COUGH SYRUP DM EXPECTORANT, +3 more | No marketed DIN |
| TECHNILAB PHARMA INC. | 9 | 0 | CALMYLIN #3 SYR, CALMYLIN CODEINE D-E SYR, DM PLUS DECONGESTANT PLUS EXPECTOR.EX.ST.SYR, DM PLUS DECONGESTANT PLUS EXPECTORANT COUGH SYRUP, DM PLUS EXPECTORANT SYRUP, +4 more | No marketed DIN |
| TRILLIUM HEALTH CARE PRODUCTS INC | 9 | 0 | COUGH & CHEST CONGESTION, COUGH & CHEST CONGESTION EXTRA STRENGTH, COUGH & COLD RELIEF, COUGH & COLD RELIEF EXTRA STRENGTH, DM EXPECTORANT (EXTRA STRENGTH) SYRUP, +4 more | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG / 5 ML |
|---|---|
| Dosage form | SYRUP |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Opium Derivatives And Expectorants |
|---|---|
| ATC code | R05FA02 |
| AHFS class | 48:08.00 ; 48:16.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01931024 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1931024 |
| Brand name | ROBITUSSIN COUGH CONTROL |
| Generic / active ingredient | GUAIFENESIN : 100 MG / 5 ML DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML |
| Market authorization holder | HALEON CANADA ULC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R05FA02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R05FA |
| Current status | MARKETED |
| Status date | 12-Jun-2024 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
25 of 156 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02265419 |
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02003317 |
| BENYLIN EXTRA STRENGTH COUGH COMPLETE | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02265400 |
| BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02436485 |
| BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02320959 |
| BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 01944762 |
| CALMYLIN | 12.5 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 00535230 |
| CALMYLIN ACE | 10 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 02198630 |
| CALMYLIN PSE WITH CODEINE | 3.3 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 02172917 |
| COUGH & CHEST CONGESTION | 20 MG / 20 ML | SYRUP | JUNO OTC INC | MARKETED | 02539195 |
2 · Same class — other molecules in ATC R05FA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Opium Derivatives And Expectorants | BALMINIL CODEINE + DECONGESTANT + EXPECTORANT · BALMINIL CODEINE NIGHT TIME + EXPECTORANT · BALMINIL DM + DECONGESTANT + EXPECTORANT · BALMINIL DM + DECONGESTANT + EXPECTORANT EXTRA STRENGTH · +140 more | 156 | 25 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R05F
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R05FB | Cough Suppressants And Expectorants | 12 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ROBITUSSIN COUGH CONTROL called?
The same molecule, Opium Derivatives And Expectorants, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Dropizol | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.